Tag: Nursing

[Solved] Pharm week 2 Reply to Peer 1

✓ Verified Academic Solution Available

Executive Solution Overview

1-For the pharmacologic management of AM, who presents a corneal abrasion associated with contact lens wear, we recommend the immediate suspension of the lenses and the instauration of a broad spectrum antibiotic eye drop with activity against Pseudomonas, preferably a fourth generation fluoroquinol…

Instant Solution Download
$6.99

Immediate access to the full model answer, formatted citations, and rubric breakdown.

Need a Fresh Custom Paper?

Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →

Assignment Prompt & Instructions

1-For the pharmacologic management of AM, who presents a corneal abrasion associated with contact lens wear, we recommend the immediate suspension of the lenses and the instauration of a broad spectrum antibiotic eye drop with activity against Pseudomonas, preferably a fourth generation fluoroquinolone (for example, moxifloxacin or gatifloxacin) in an initial schedule of instillation every 2-4 hours during the first 24-48 hours and then four times a day until complete epithelial healing. Intensive lubrication with artificial tears is associated to favor re-epithelialization and a cycloplegic eye drop (homatropine 1%) can be added once a day to alleviate pain due to ciliary spasm. Anesthetics should not be prescribed because of the risk of delayed healing and corneal complications (Cassano et al., 2021).

2-AM should be re-evaluated within 24 to 48 hours to check for complete healing of the corneal epithelium and to rule out the appearance of infiltrates or signs of infection; at this visit, visual acuity should be assessed, fluorescein staining should be repeated and if possible, slit-lamp examination should be performed to confirm closure of the epithelial defect and the absence of edema or stromal inflammation. During follow-up it is essential to reinforce the total suspension of contact lenses until complete recovery, to insist on the correct instillation of antibiotic and lubricants, and to monitor the appearance of alarm symptoms, increased pain, hypopyon, purulent discharge or worsening of vision that would require urgent referral to an ophthalmologist. Once the erosion has closed without complications, adaptation to new contact lenses can be started gradually under specialized supervision (Kobia-Acquah et al., 2021).

3-AM should be advised to immediately discontinue contact lens wear until complete healing of the corneal epithelium to avoid the introduction of microorganisms and prevent the development of Pseudomonas keratitis or other pathogens. Once the ophthalmologist confirms corneal repair, AM should debut a new pair of monthly lenses, strictly adhere to the replacement schedule, employ proper cleaning and disinfection techniques, and avoid swimming, showering or sleeping with the lenses to minimize the risk of reinfection and new abrasions (Flanagan et al., 2020).

References

Cassano, F., Cardascia, N., Tegola, M. G. L., Boscia, F., & Alessio, G. (2021). Scedosporium apiospermum contact lens-related keratitis: A case report and literature review. _Medical Hypothesis, Discovery & Innovation Ophthalmology Journal_, _10_(2), 80–85. https://doi.org/10.51329/mehdiophthal1425

Flanagan, G., Velez, T., Gu, W., & Singman, E. (2020). Contact Lens Wear, Corneal Complications, and U.S. Service Member Readiness. _Military Medicine_, _185_(11–12), e2071–e2075. https://doi.org/10.1093/milmed/usaa187

Kobia-Acquah, E., Akowuah, P. K., Antwi-Adjei, E. K., Forkuo, P. M., Koomson, N. Y., Odotei, S. O., Alabi, E., & Donkor, R. (2021). Contact lens complications among wearers in Ghana. _Contact Lens & Anterior Eye: The Journal of the British Contact Lens Association_, _44_(1), 67–71. https://doi.org/10.1016/j.clae.2019.11.003

– a year ago

November 5, 2026
[Solved] nursing theories week 1

✓ Verified Academic Solution Available

Executive Solution Overview

In-depth study guidance and analytical solution covering nursing theories week 1.

Instant Solution Download
$6.99

Immediate access to the full model answer, formatted citations, and rubric breakdown.

Need a Fresh Custom Paper?

Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →

Assignment Prompt & Instructions

Full assignment prompt and step-by-step guidance are included in the downloadable solution file.

November 5, 2026
[Solved] Nursing assignment 582 week 4

✓ Verified Academic Solution Available

Executive Solution Overview

Reflect on the mission, vision, and values of a workplace organization and how the workplace organization addresses a culture of excellence. Note: you may use the same workplace organization that you discussed in this week's Collaboration Café. (RWJBarnabas Health) Use Canva.com or another platform …

Instant Solution Download
$6.99

Immediate access to the full model answer, formatted citations, and rubric breakdown.

Need a Fresh Custom Paper?

Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →

Assignment Prompt & Instructions

Reflect on the mission, vision, and values of a workplace organization and how the workplace organization addresses a culture of excellence. Note: you may use the same workplace organization that you discussed in this week's Collaboration Café. (RWJBarnabas Health)

Use Canva.com or another platform of your choice to create an infographic

1. Ensure the infographic is readable.
2. Ensure the infographic is well-organized and easy to follow.
3. Correctly cite and reference ideas and information that come from scholarly sources of information. Include in-text citations and list references at the bottom of the infographic.
4. Follow rules of grammar, spelling, word usage, and punctuation consistent with formal, scientific writing.
5. Abide by Chamberlain University academic integrity policy.
6. Submit the completed infographic as a PDF or JPG file to the assignment Dropbox.
7. Submit a screenshot of the completed infographic.
1. Highlight the date and time your infographic was created as shown in the image below.
2. The submitted infographic must match the screenshot and reflect the current academic session.

Include the following sections/headings in the infographic.

1. Culture of Excellence
1. Explain the concept of a culture of excellence in healthcare.
2. Identify three specific organizational characteristics or practices that reflect a culture of excellence and briefly describe each characteristic or practice.
3. Discuss how a culture of excellence is significant to your selected advanced nursing role in one or two sentences.
4. Provide support from at least one scholarly source.
2. Mission, Vision, and Values
1. Describe the mission, vision, and values of a selected healthcare organization (note: the organization you choose must have all three elements: mission, vision, and values statements).
2. Explain the interrelationships of the mission, vision, and values in one or two sentences.
3. Describe how an organization’s mission, vision, values, and organizational structure contribute to organizational culture in one or sentences.
3. Leading a Culture of Excellence
1. Describe how the advanced nurse leader can leverage the mission, vision, values, and organizational structure to create positive change in the organizational culture in one or two sentences.
2. Identify two leadership strategies the advanced nurse leader can use to support a culture of excellence and briefly describe each strategy.
3. Provide support from at least one scholarly source.

please provide AI and Similarity report

– [\
\
Screenshot2025-05-15210104.png](https://www.sweetstudy.com/files/screenshot2025-05-15210104-png "Screenshot2025-05-15210104.png")

– a year ago

November 5, 2026
[Solved] Asssigment

✓ Verified Academic Solution Available

Executive Solution Overview

– a year ago **files (1)** – ## powerpointe.docx **## powerpointe.docx** **Educational Program on Risk Management** Submit Assignment Start Date May 12, 2025, 12:00 AM Due Date May 18, 2025, 11:59 PM Points 200 Rubric [View Rubric](https://halo.gcu.edu/courses/HLT-308V-O500-20250505/rubrics/42596ee3…

Instant Solution Download
$6.99

Immediate access to the full model answer, formatted citations, and rubric breakdown.

Need a Fresh Custom Paper?

Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →

Assignment Prompt & Instructions

– a year ago

**files (1)**

– ## powerpointe.docx

**## powerpointe.docx**

**Educational Program on Risk Management**

Submit Assignment

Start Date

May 12, 2025, 12:00 AM

Due Date

May 18, 2025, 11:59 PM

Points

200

Rubric

[View Rubric](https://halo.gcu.edu/courses/HLT-308V-O500-20250505/rubrics/42596ee3-f0f9-49e0-bb18-b4c76b1e6236)

Status

**Active**

Assessment Traits

Requires Lopeswrite

Assessment Description

The purpose of this assignment is to create an educational program that supports the implementation of risk management strategies in a health care organization.

In this assignment, you will develop an "in‐service"‐style educational risk management program presentation for the employer and employees of a particular health care organization. Select your topic for this educational session from one of the proposed recommendations or changes you suggested in the Topic 1 benchmark assignment to enhance, improve, or secure compliance standards in your chosen risk management plan example.

Develop a 10-12-slide presentation (including a title slide, a reference slide, and slide notes that provide a detailed explanation of your research) that outlines the following points about your chosen topic:

·
**_Introduction:_** Identify the risk management topic you have chosen to address and explain why it is important within your health care sector.

·
**_Rationale:_** Explain how this risk management strategy is lacking within your selected organization's current risk management plan and describe how its responsibility for implementation will better meet local, state, and federal compliance standards.

·
**_Support:_** Provide data that indicate the need for this proposed risk management initiative and explain how it falls under the organization's legal responsibility to provide a safe health care facility and work environment.

·
**_Implementation:_** Describe the steps to implement the proposed strategy in your selected health care organization.

·
**_Challenges:_** Predict obstacles the health care organization may face in executing this risk management strategy and challenges for building a culture of faith, compassion, and concern for patients, families, and employees, and propose solutions to navigate or preempt these potentially difficult outcomes.

·
**_Evaluation:_** Outline your plan to evaluate the success of the proposed risk management program and how well it meets compliance with operational risk management policies in the organization's short-term, long-term, and end goals, which includes key employer and employee metrics that will be used for measuring the success of the risk management program.

·
**_Opportunities:_** Recommend additional risk management improvements in adjacent areas of influence that the organization could or should address moving forward.

In addition to your textbook and the GCU "Statement on the Integration of Faith and Work," you are required to support your analysis with at least three credible health-related resources and at least three peer-reviewed resources.

Refer to the resource, "Creating Effective PowerPoint Presentations," located in the Student Success Center, for additional guidance on completing this assignment in the appropriate style.

While APA style is not required for the body of this assignment, solid academic writing is expected, and documentation of sources should be presented using APA formatting guidelines, which can be found in the APA Style Guide, located in the Student Success Center.

This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.

You are required to submit this assignment to LopesWrite. A link to the LopesWrite technical support articles is located in Class Resources if you need assistance.

**Topic 2 Participation**

**Rubric Criteria**

expand all Rubric CriteriaExpand All

**Introduction**

20 points

**Criteria Description**

Identification of the risk management topic chosen and explanation of why it is important within the health care sector.

**5. Target**

20 points

Identification of the risk management topic chosen and explanation of why it is important within the health care sector are comprehensive. The submission encompasses essential details and provides convincing support.

**Rationale**

20 points

**Criteria Description**

Explanation of how this risk management strategy is lacking within the selected organization's current risk management plan and how its responsibility for implementation will better meet local, state, and federal compliance standards.

**5. Target**

20 points

Explanation of how this risk management strategy is lacking within the selected organization's current risk management plan and how its responsibility for implementation will better meet local, state, and federal compliance standards is comprehensive. The submission encompasses essential details and provides convincing support.

**Support**

20 points

**Criteria Description**

Provision of data that indicate the need for this proposed risk management initiative and explanation of how it falls under the organization's legal responsibility to provide a safe health care facility and work environment.

**5. Target**

20 points

Provision of data that indicate the need for this proposed risk management initiative and explanation of how it falls under the organization's legal responsibility to provide a safe health care facility and work environment is comprehensive. The submission encompasses essential details and provides convincing support.

**Implementation**

20 points

**Criteria Description**

Description of the steps to implement the proposed strategy in the selected health care organization.

**5. Target**

20 points

Description of the steps to implement the proposed strategy in the selected health care organization is comprehensive. The submission encompasses essential details and provides convincing support.

**Challenges**

20 points

**Criteria Description**

Prediction of obstacles the health care organization may face in executing this risk management strategy and challenges for building a culture of faith, compassion, and concern for patients, families, and employees, and proposal of solutions to navigate or preempt these potentially difficult outcomes

**5. Target**

20 points

Prediction of obstacles the health care organization may face in executing this risk management strategy and challenges for building a culture of faith, compassion, and concern for patients, families, and employees, and proposal of solutions to navigate or preempt these potentially difficult outcomes is comprehensive. The submission encompasses essential details and provides convincing support.

**Evaluation**

20 points

**Criteria Description**

Outline of plan to evaluate the success of the proposed risk management program and how well it meets compliance with operational risk management policies in the organization's short-term, long-term, and end goals, which includes key employer and employee metrics that will be used for measuring the success of the risk management program.

**5. Target**

20 points

Outline of plan to evaluate the success of the proposed risk management program and how well it meets compliance with operational risk management policies in the organization's short-term, long-term, and end goals, which includes key employer and employee metrics that will be used for measuring the success of the risk management program, is comprehensive. The submission encompasses essential details and provides convincing support.

**Opportunities**

20 points

**Criteria Description**

Recommendation of additional risk management improvements in adjacent areas of influence that the organization could or should address moving forward.

**5. Target**

20 points

Recommendation of additional risk management improvements in adjacent areas of influence that the organization could or should address moving forward is comprehensive. The submission encompasses essential details and provides convincing support.

**## powerpointe.docx**

**Educational Program on Risk Management**

Submit Assignment

Start Date

May 12, 2025, 12:00 AM

Due Date

May 18, 2025, 11:59 PM

Points

200

Rubric

[View Rubric](https://halo.gcu.edu/courses/HLT-308V-O500-20250505/rubrics/42596ee3-f0f9-49e0-bb18-b4c76b1e6236)

Status

**Active**

Assessment Traits

Requires Lopeswrite

Assessment Description

The purpose of this assignment is to create an educational program that supports the implementation of risk management strategies in a health care organization.

In this assignment, you will develop an "in‐service"‐style educational risk management program presentation for the employer and employees of a particular health care organization. Select your topic for this educational session from one of the proposed recommendations or changes you suggested in the Topic 1 benchmark assignment to enhance, improve, or secure compliance standards in your chosen risk management plan example.

Develop a 10-12-slide presentation (including a title slide, a reference slide, and slide notes that provide a detailed explanation of your research) that outlines the following points about your chosen topic:

·
**_Introduction:_** Identify the risk management topic you have chosen to address and explain why it is important within your health care sector.

·
**_Rationale:_** Explain how this risk management strategy is lacking within your selected organization's current risk management plan and describe how its responsibility for implementation will better meet local, state, and federal compliance standards.

·
**_Support:_** Provide data that indicate the need for this proposed risk management initiative and explain how it falls under the organization's legal responsibility to provide a safe health care facility and work environment.

·
**_Implementation:_** Describe the steps to implement the proposed strategy in your selected health care organization.

·
**_Challenges:_** Predict obstacles the health care organization may face in executing this risk management strategy and challenges for building a culture of faith, compassion, and concern for patients, families, and employees, and propose solutions to navigate or preempt these potentially difficult outcomes.

·
**_Evaluation:_** Outline your plan to evaluate the success of the proposed risk management program and how well it meets compliance with operational risk management policies in the organization's short-term, long-term, and end goals, which includes key employer and employee metrics that will be used for measuring the success of the risk management program.

·
**_Opportunities:_** Recommend additional risk management improvements in adjacent areas of influence that the organization could or should address moving forward.

In addition to your textbook and the GCU "Statement on the Integration of Faith and Work," you are required to support your analysis with at least three credible health-related resources and at least three peer-reviewed resources.

Refer to the resource, "Creating Effective PowerPoint Presentations," located in the Student Success Center, for additional guidance on completing this assignment in the appropriate style.

While APA style is not required for the body of this assignment, solid academic writing is expected, and documentation of sources should be presented using APA formatting guidelines, which can be found in the APA Style Guide, located in the Student Success Center.

This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.

You are required to submit this assignment to LopesWrite. A link to the LopesWrite technical support articles is located in Class Resources if you need assistance.

**Topic 2 Participation**

**Rubric Criteria**

expand all Rubric CriteriaExpand All

**Introduction**

20 points

**Criteria Description**

Identification of the risk management topic chosen and explanation of why it is important within the health care sector.

**5. Target**

20 points

Identification of the risk management topic chosen and explanation of why it is important within the health care sector are comprehensive. The submission encompasses essential details and provides convincing support.

**Rationale**

20 points

**Criteria Description**

Explanation of how this risk management strategy is lacking within the selected organization's current risk management plan and how its responsibility for implementation will better meet local, state, and federal compliance standards.

**5. Target**

20 points

Explanation of how this risk management strategy is lacking within the selected organization's current risk management plan and how its responsibility for implementation will better meet local, state, and federal compliance standards is comprehensive. The submission encompasses essential details and provides convincing support.

**Support**

20 points

**Criteria Description**

Provision of data that indicate the need for this proposed risk management initiative and explanation of how it falls under the organization's legal responsibility to provide a safe health care facility and work environment.

**5. Target**

20 points

Provision of data that indicate the need for this proposed risk management initiative and explanation of how it falls under the organization's legal responsibility to provide a safe health care facility and work environment is comprehensive. The submission encompasses essential details and provides convincing support.

**Implementation**

20 points

**Criteria Description**

Description of the steps to implement the proposed strategy in the selected health care organization.

**5. Target**

20 points

Description of the steps to implement the proposed strategy in the selected health care organization is comprehensive. The submission encompasses essential details and provides convincing support.

**Challenges**

20 points

**Criteria Description**

Prediction of obstacles the health care organization may face in executing this risk management strategy and challenges for building a culture of faith, compassion, and concern for patients, families, and employees, and proposal of solutions to navigate or preempt these potentially difficult outcomes

**5. Target**

20 points

Prediction of obstacles the health care organization may face in executing this risk management strategy and challenges for building a culture of faith, compassion, and concern for patients, families, and employees, and proposal of solutions to navigate or preempt these potentially difficult outcomes is comprehensive. The submission encompasses essential details and provides convincing support.

**Evaluation**

20 points

**Criteria Description**

Outline of plan to evaluate the success of the proposed risk management program and how well it meets compliance with operational risk management policies in the organization's short-term, long-term, and end goals, which includes key employer and employee metrics that will be used for measuring the success of the risk management program.

**5. Target**

20 points

Outline of plan to evaluate the success of the proposed risk management program and how well it meets compliance with operational risk management policies in the organization's short-term, long-term, and end goals, which includes key employer and employee metrics that will be used for measuring the success of the risk management program, is comprehensive. The submission encompasses essential details and provides convincing support.

**Opportunities**

20 points

**Criteria Description**

Recommendation of additional risk management improvements in adjacent areas of influence that the organization could or should address moving forward.

**5. Target**

20 points

Recommendation of additional risk management improvements in adjacent areas of influence that the organization could or should address moving forward is comprehensive. The submission encompasses essential details and provides convincing support.

November 5, 2026
[Solved] unit 2 journal

✓ Verified Academic Solution Available

Executive Solution Overview

see attached – a year ago **files (2)** – ## 673unit2journal.docx – NU673_Assignment_Rubrics.docx **## 673unit2journal.docx** This reflective journal assignment will allow you to investigate areas for clinical preparation in psychiatric mental health. The reflective journal should be written simil…

Instant Solution Download
$6.99

Immediate access to the full model answer, formatted citations, and rubric breakdown.

Need a Fresh Custom Paper?

Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →

Assignment Prompt & Instructions

see attached

– a year ago

**files (2)**

– ## 673unit2journal.docx

– NU673_Assignment_Rubrics.docx

**## 673unit2journal.docx**

This reflective journal assignment will allow you to investigate areas for clinical preparation in psychiatric mental health. The reflective journal should be written similarly to a Discussion Board post and abide by APA writing standards for use of appropriate citations. Your journal should include a minimum of one reference in APA format and be a minimum of 250 words.

Review the following articles related to posttraumatic stress disorder in older adults:

·
[**“Posttraumatic Stress Disorder in Older Adults: A Conceptual Review**](https://pubmed.ncbi.nlm.nih.gov/30422749/)”

·
[**“Post-Traumatic Stress Disorder in Older Adults**](https://mha.ohio.gov/static/learnandfindhelp/TreatmentServices/TCC/Post-Traumatic-Stress-Disorder-in-Older-Adults.pdf)”

1. What is the significance of PTSD among older adults? Discuss the common symptoms associated with PTSD.

2. What are the key components of trauma-informed care?

3. Discuss the impact of trauma on older veterans.

4. Explain the neurocognitive changes associated with PTSD in older adults.

5. How will you apply clinical judgment in differentiating trauma symptoms and physical symptoms associated with trauma among the geriatric population?

**NU673_Assignment_Rubrics.docx**

This file is too large to display. [View in new window](https://www.sweetstudy.com/files/nu673-assignment-rubrics-docx)

**NU673_Assignment_Rubrics.docx**

This file is too large to display. [View in new window](https://www.sweetstudy.com/files/nu673-assignment-rubrics-docx)

**## 673unit2journal.docx**

This reflective journal assignment will allow you to investigate areas for clinical preparation in psychiatric mental health. The reflective journal should be written similarly to a Discussion Board post and abide by APA writing standards for use of appropriate citations. Your journal should include a minimum of one reference in APA format and be a minimum of 250 words.

Review the following articles related to posttraumatic stress disorder in older adults:

·
[**“Posttraumatic Stress Disorder in Older Adults: A Conceptual Review**](https://pubmed.ncbi.nlm.nih.gov/30422749/)”

·
[**“Post-Traumatic Stress Disorder in Older Adults**](https://mha.ohio.gov/static/learnandfindhelp/TreatmentServices/TCC/Post-Traumatic-Stress-Disorder-in-Older-Adults.pdf)”

1. What is the significance of PTSD among older adults? Discuss the common symptoms associated with PTSD.

2. What are the key components of trauma-informed care?

3. Discuss the impact of trauma on older veterans.

4. Explain the neurocognitive changes associated with PTSD in older adults.

5. How will you apply clinical judgment in differentiating trauma symptoms and physical symptoms associated with trauma among the geriatric population?

**NU673_Assignment_Rubrics.docx**

This file is too large to display. [View in new window](https://www.sweetstudy.com/files/nu673-assignment-rubrics-docx)

**## 673unit2journal.docx**

This reflective journal assignment will allow you to investigate areas for clinical preparation in psychiatric mental health. The reflective journal should be written similarly to a Discussion Board post and abide by APA writing standards for use of appropriate citations. Your journal should include a minimum of one reference in APA format and be a minimum of 250 words.

Review the following articles related to posttraumatic stress disorder in older adults:

·
[**“Posttraumatic Stress Disorder in Older Adults: A Conceptual Review**](https://pubmed.ncbi.nlm.nih.gov/30422749/)”

·
[**“Post-Traumatic Stress Disorder in Older Adults**](https://mha.ohio.gov/static/learnandfindhelp/TreatmentServices/TCC/Post-Traumatic-Stress-Disorder-in-Older-Adults.pdf)”

1. What is the significance of PTSD among older adults? Discuss the common symptoms associated with PTSD.

2. What are the key components of trauma-informed care?

3. Discuss the impact of trauma on older veterans.

4. Explain the neurocognitive changes associated with PTSD in older adults.

5. How will you apply clinical judgment in differentiating trauma symptoms and physical symptoms associated with trauma among the geriatric population?

**NU673_Assignment_Rubrics.docx**

This file is too large to display. [View in new window](https://www.sweetstudy.com/files/nu673-assignment-rubrics-docx)

November 5, 2026
[Solved] YULE-DISC 3

✓ Verified Academic Solution Available

Executive Solution Overview

#### **Discussion Topic:** **What are the major concepts of the self-efficacy theory, and how are they defined? Describe a patient situation that highlights each of the major concepts as defined.** #### **Instructions:** #### **1. Introduction and Overview** – **Begin with an Introduction:** – Prov…

Instant Solution Download
$6.99

Immediate access to the full model answer, formatted citations, and rubric breakdown.

Need a Fresh Custom Paper?

Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →

Assignment Prompt & Instructions

#### **Discussion Topic:**

**What are the major concepts of the self-efficacy theory, and how are they defined? Describe a patient situation that highlights each of the major concepts as defined.**

#### **Instructions:**

#### **1. Introduction and Overview**

– **Begin with an Introduction:**
– Provide a brief overview of self-efficacy theory. Explain its origin (e.g., Bandura’s work in social cognitive theory) and its significance in both nursing and broader healthcare contexts.
– State the purpose of your discussion—to analyze and define the core concepts of self-efficacy theory and illustrate each with real or hypothetical patient scenarios.

#### **2. Define the Major Concepts of Self-Efficacy Theory**

– **Identify and Explain Key Components:** Your discussion should include a detailed explanation of the major concepts of self-efficacy theory. Typically, you must discuss:
– **Self-Efficacy Beliefs:**
– **Definition:** Describe self-efficacy as a person’s belief in their ability to execute behaviors necessary to produce specific performance attainments.
– **Explanation:** Consider how this belief influences decisions, motivation, and actions.
– **Sources of Self-Efficacy:**
– **Mastery Experiences:**
– **Definition:** These are past experiences of success that build confidence in one’s abilities.
– **Explanation:** Explain how successfully overcoming challenges reinforces positive self-beliefs.
– **Vicarious Experiences:**
– **Definition:** Also known as observational learning, these are gained by watching others succeed.
– **Explanation:** Discuss how seeing peers or role models overcome similar challenges can boost one’s own self-confidence.
– **Verbal Persuasion:**
– **Definition:** This involves encouragement or feedback from others that can influence self-perception.
– **Explanation:** Analyze how positive reinforcement from healthcare providers, family members, or peers can enhance self-efficacy.
– **Physiological and Affective States:**
– **Definition:** These refer to the physical and emotional states that can affect an individual’s confidence in their ability to perform tasks.
– **Explanation:** Describe how anxiety, stress, or fatigue might impact self-efficacy, and conversely, how a calm and supportive environment may improve it.
– **Contextual Integration:**
– If your course or readings include additional or alternative components (such as outcome expectations), include them and provide clear definitions.

#### **3. Provide Clinical Examples for Each Concept**

– **Link Concepts to Patient Situations:** For each major concept described, provide a clinical scenario that illustrates its relevance:
– **Mastery Experiences Example:**
– Describe a situation where a patient’s progress (like recovering after surgery or learning self-care in diabetes management) builds their confidence to manage future challenges.
– **Vicarious Experiences Example:**
– Share a scenario where observing another patient’s success (perhaps in a support group or peer-led class) helped a patient believe in their own ability to improve.
– **Verbal Persuasion Example:**
– Offer an example where a nurse or healthcare provider used encouragement and positive feedback to help a patient overcome hesitation or fear regarding a treatment.
– **Physiological and Affective States Example:**
– Provide a situation where a patient’s physical responses (such as stress or anxiety) played a role in their self-efficacy. For instance, how calming interventions and emotional support reduced their physiological stress, leading to better self-management.
– **Detail Your Examples:**
– For each patient situation, include enough context so that the reader understands the circumstances.
– Explain explicitly how the example demonstrates the specific concept. This may include outlining what happened, what was observed, and the impact on the patient’s belief in their ability to manage their health condition.

#### **4. Evidence-Based Support**

– **Integrate Scholarly Sources:**
– Support your definitions and examples with evidence from peer-reviewed articles, textbooks, or healthcare research studies.
– Ensure you cite at least two scholarly sources that discuss the self-efficacy theory and its applications in nursing practice.
– Use APA 7th Edition for all in-text citations and the reference list.

#### **5. Synthesis and Conclusion**

– **Wrap Up Your Discussion:**
– Summarize the key points you presented about the major concepts of self-efficacy theory.
– Reflect on why understanding these concepts is crucial for enhancing patient outcomes and guiding nursing practice.
– Offer a final thought on how nurses can harness self-efficacy as a tool to empower patients throughout their care journeys.

#### **6. Format and Submission Guidelines**

– **Structure:**
– Write a well-organized post with an introduction, body sections (each clearly addressing a major concept and its clinical example), and a conclusion.
– Ensure smooth transitions between sections for clarity.
– **Length:**
– Be sure your post meets the minimum word count as specified by your instructor (if any is provided in your course guidelines).
– **APA Formatting:**
– Follow APA 7th Edition formatting for the entire discussion post.
– Include a reference list at the end with all the sources you cited.
– **Engagement:**
– After posting your initial discussion, interact with at least two peers by providing thoughtful responses or additional insights.

As a reminder, all discussion posts must be a minimum of 400 words initial references must be cited in APA format 7th Edition and must include a minimum of 2 scholarly resources published within the past 5 years.

NO PLAGIARISM

DUE DATE MAY 18, 2025

– a year ago

November 5, 2026
[Solved] week 2 DB response 2

✓ Verified Academic Solution Available

Executive Solution Overview

see attachment – a year ago **files (1)** – ## Week2DBresponse2-.pdf **## Week2DBresponse2-.pdf** Table 1 Infection Description Presentation Causes/ Risk Factors Treatment per CDC Addtl info Candida Fungal infection due to candida albicans Pruritic, soreness, dyspareunia , occasionally thick vaginal…

Instant Solution Download
$6.99

Immediate access to the full model answer, formatted citations, and rubric breakdown.

Need a Fresh Custom Paper?

Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →

Assignment Prompt & Instructions

see attachment

– a year ago

**files (1)**

– ## Week2DBresponse2-.pdf

**## Week2DBresponse2-.pdf**

Table 1

Infection Description Presentation Causes/ Risk
Factors

Treatment per
CDC

Addtl
info

Candida

Fungal
infection due
to candida
albicans

Pruritic,
soreness,
dyspareunia
,
occasionally
thick
vaginal
discharge
and dysuria.
KOH
demonstrate
s budding

Pregnancy,
immunosupression,
antibiotic use,
diabetes

– Fluconazole 150
mg single dose

Not
usually
considere
d an STI.

BV

Vaginal
discharge or
malodorous in
childbearing
people. N

Mal-
odorous/
fishy odor,
thin gray-
white
discharge,
clue cells on

sexual activity,
particularly with
new or multiple
partners, the use of
douching, and not
using condoms

Metronidazole 500
mg BID x 7 days
OR 0.75% gel x 5
days

Not
sexually
transmittt
ed

Chlamydi
a

STI caused by
Chlamydia
trachomatis

Often
Asymptoma
tic;
cervicitis,
urethritis,
dysuria,
postcoital
bleeding

having multiple or
new sexual
partners, not using
condoms during
sex, and having a
history of other
STIs

Doxycycline 100
mg BID x 7 days
(preferred); or
Azithromycin 1 g
PO x1

Sexually
transmitt
ed;
screen
annually

Gonorrhe
a

STI caused by
Nisseria
gonorrheae

Purulent
discharge,
pelvic pain,
dysuria,
urethritis,
often
asymptomat
ic in women

unprotected sex,
having multiple
sexual partners, a
history of other
sexually
transmitted
infections (STIs),
and being a young
adult (under 25)

Ceftriaxone 500
mg IM x1 (if <150
kg); treat
Chlamydia
empirically unless
ruled out

Sexually
transmitt
ed,
screen
annually

Trichomo
nas

STI caused by
Trichomonas
vaginalis

Frothy
yellow-
green
discharge,
strawberry
cervix, foul
odor,

Multiple partners,
unprotected sex

Metronidazole 500
mg BID x 7 days
or 2g PO x1

Sexually
transmitt
ed,
partner
needs to
be
treated

Cervicitis
Inflammation
of cervix due
to STI

Mucopurule
nt
discharge,
cervical
bleeding
with contact

Chlamydia,
Gonorrhea, HSV

Treat based on
organism;
empirically cover
Chlamydia &
Gonorrhea

Can
cause
PID if
not
treater

PID

Ascending
polymicrobial
infection of
upper genital
tract

Pelvic pain,
cervical
motion
tenderness,
fever,
discharge

Untreated
Chlamydia/
Gonorrhea,
multiple partners

Ceftriaxone 500
mg IM x1 +
Doxycycline 100
mg BID x 14d

Metronidazole

Risk for
infertility

HIV

Human
immunodeficie
ncy virus , a
virus that
attacks cells
that help the
body fight
infection.
Affects the

Acute: flu-
like
symptoms

Chronic:
becomes
opportunisti
c infection

Unprotected sex,
IV drug use, MSM,
mother-to-child

ART
(Antiretroviral
therapy) – lifelong

Screenin
g should
be
offered
annually

Syphilis
STI caused by
treponema
pallidum

Primary:
Painless
chancre

Secondary:
rash on
palms, soles

Tertiary:
neurological
and cardiac
involvement

MSM, HIV+,
multiple partners,
unprotected sex

Benzathine
penicillin G 2.4M
units IM x1
(early); weekly x3
(late/unknown
duration)

Screen
all
pregnant
patients,
treat
partners.

Table 2

Hep B

hepatitis B
virus is a small
DNA virus that
belongs to the
“Hepadnavirid
ae” family.

Fatigue,
jaundice,
RUQ pain

Sexual contact, IV
drug use, perinatal
transmission,
healthcare
exposure

Supportive care
(acute); Antivirals
for chronic (e.g.,
tenofovir,
entecavir)

Screenin
g done to
all
pregnant
patients,
vaccine
available

Hep C

Hepatitis C is a
viral infection
that causes
liver swelling,
called
inflammation.
Hepatitis C can
lead to serious
liver damage.

Faituge,
jaundice

IV drug use, blood
transfusions
(pre-1992), sexual
exposure

Direct-acting
antivirals (e.g.,
sofosbuvir/
velpatasvir) for 8–
12 weeks

Screen
adults, no
vaccine
available

HSV

Herpes
Simplex Virus.
Herpes is a
common virus
that can cause
cold sores or
genital sores. It
spreads
through skin-
to-skin contact

Painless
vesciles or
ulcers,
dysuria,
systemic
symptoms
during
primary
infection

Oral/genital
contact,
unprotected sex,
vertical
transmission

Acyclovir 400 mg
TID x 7–10 days
or Valacyclovir 1g
BID x 7–10 days

Lifelong
therapy

Question Answer

Name 10 Risk Factors for contracting STI’s
and HIV

1. Having unprotected sex

2. Having multiple partners

3. Injection of drugs with dirty needle
sharing.

4. History of previous STI

5. Substance use

6. Sex work or transactional sex

7. Lac of access to healthcare or education

8. Not being vaccinated against preventable
STIs

9. Being incarcerated or having a partner
who is

10.Sexual coercion or violence

Name 5 safer sex practices

1. Limiting sexual partners

2. Regular STI testing, especially with new
partners

3. Use condoms every tine you have sex

4. Avoid sex under the influence of drugs or
alcohol

5. Inspect partners for visible sore or
symptoms

Can HIV be transmitted through sweat, saliva,
and tears? (Include rationale)

No, HIV can be transmitted from one infected
person to another through blood, semen,
vaginal secretions, rectal fluids and breast
milk. For HIV to occur, the HIV in these fluids
must get into the bloodstream of an HIV-
negative person through a mucous membrane
through open cuts or sores, or by direct
injection.

Lisa is a 19-year-old female who presents to the clinic c/o abnormal vaginal discharge for one
week after having unprotected vaginal intercourse with a new male partner she has been dating
for a couple of weeks. Lisa’s pregnancy test is negative and her LMP was 2 weeks ago. As her
health care provider, you will need to perform testing to determine if Lisa has contracted a
sexually transmitted infection or other vaginal infection.

SOAP NOTE

Demographic: 19/ Female G0P0

Subjective

Chief complain: “abnormal vaginal discharge for one week after having unprotected vaginal
intercourse with a new male partner that I have been dating for a couple of weeks.”

Name 2 types of intercourse are at the highest
risk for contracting HIV

1. Unprotected vaginal sex

2. Unprotected anal sex

Why are women more susceptible to HIV in a
male to female relationship (versus a male
contracting it from a female)?

In women, several factors can increase the risk
of HIV transmission. For example, during
vaginal or anal intercourse, women are at
greater risk of acquiring HIV because
receptive sex is generally riskier than insertive
sex. Age-related thinning and dryness of the
vaginal tissue—common in older women—
can lead to microtears during intercourse,
providing a pathway for HIV transmission.
Biologically, women are more vulnerable to
infection due to the larger mucosal surface
area exposed during penile penetration.
Additionally, young women under the age of
17 are at even higher risk because they have
an underdeveloped cervix and produce less
protective vaginal mucus.

HPI:

Lisa is a 19 year ld female G0P0 who presents with a one week history of abnormal discharge
after having unprotected vaginal intercourse with a new male partner.

• Onset: one week
• Locating: vaginal
• Duration: ongoing
• Characteristic: abnormal
• Aggrevating/relieving factors: none stated
• Treatment: none tried

HPI questions:

• Is there any vaginal itching, burning or odor?
• Are you having any symptoms such as cramping, pelvic pain, fever, burning when you pee?
• Have you had this type of discharge in the past?
• When was the last time you were tested for STIs?

Gyn history:

• LMP: 2 weeks ago, stated, regular
• Unknown if on birth control at this time
• Sexually active, new male partner, no protection
• No known gynocological issues at this time.

Medical history

• No known medical conditions
• No known surgical conditions
• No known drug allergies
• Immunizations: up to date

Family history:

• Mother: no known medical history
• Father: no known medical history
• Maternal grandmother: no known medical history
• Paternal grandmother: no known medical history,

Social history

• Goes to school

• Balanced diet
• Regular exercise
• No drug or alcohol use
• Sexual history: one new male partner, no protection
• Relationship: new

Other questions

• Are you in a monogamous relationship?
• Do you practice safe sex?

Review of systems:

• General: healthy, denies fever denies chills
• Neuro: denies headacces or dizziness
• Cardiovascular: denies chest pain or palpitations
• Resp: denies shortness of breaeth or cough
• GI: denies nausea, vomiting or diarrhea or abdominal pain
• GU: positive abnormal discharge
• Skin: denies rash, denies new lesions
• Health maintenance: No Pap in the last 12 months due to age

Objective

Vitals: WNL

• Temp: 98.6
• BP: 120/80
• HR:78
• RR: 17
• Heihgt: 5’4”
• Weight: 135
• BMI: 23.2

Physical exam:

• General: AAOx4, no acute distress
• abdomen soft, non tender
• Pelvic:

o Vulva: normal appearance
o Vagina: abnormal discharge
o Cervix: normal
o Uterus: non tender
o Adnexa: no masses or tenderness

POCT

• Urine pregnancy : negative
o Rule out pregnancy due to age and no condom use
• Wet mount with KOH and send out check for chlamydia, gonorrhea, BV, trichomonas
o KOH to help identify yeast, or bv or trichomonas cells
• NAAT
o For STI screening

Assessment

Final diagnosis:

• Vaginal candidiasis B37.3 – clinical presentation of abnormal discharge

Differential:

• Bacterial vaginosis N76.0 – due to new sexual partner after unprotected sex
• Trichomoniasis A59.9 – due to new sexual partner after unprotected sex
• Chlamydia A56.0 – due to new sexual partner after unprotected sex

Plan

Diagnostics:

• NAAT: Chlamydia, Gonorrhea and trichomonas
• KOH for BV
• Serology for HIV, syphilis, Hep B and C
• Pap smear

Treatments:

• Fluconazole 150 mg Po x 1 dose orally

o This medication is being prescribed at tis time as it is the first line therapy for uncomplicated
candidiasis, some of the side effects are GI upset, and elevated liver enzymes. This
medication should not be prescribed if patient has a history of liver disease.

If STI positive: depending on what STI patient comes back positive for, prescriptions will
change. Both patient and partner will need to be treated and abstain from sex for a week.

Patient education:

• Risk factors for STIs
• Abstain from sex for 7 days until symptoms have resolved, and medication taken
• Practice safe sex
• Refrain from having multiple partners as it can place you at higher risks for HIV andSTIs
• Routine STI screening

Complications: if untrearted can causes recurect yeast infectons, risk of spreading infection to
partner and increased risk for HIV and other STIs.

Referals: refer to GYN follow up

Follow up;

• Office will call when lab results return
• Follow up in one week if symptoms do not improve
• Pap smear

Health maintenance:

• Pap smear starting at age 21
• Hpv vaccine
• STI screening annualy or whena new partner
• Up to date on vaccines

**## Week2DBresponse2-.pdf**

Table 1

Infection Description Presentation Causes/ Risk
Factors

Treatment per
CDC

Addtl
info

Candida

Fungal
infection due
to candida
albicans

Pruritic,
soreness,
dyspareunia
,
occasionally
thick
vaginal
discharge
and dysuria.
KOH
demonstrate
s budding

Pregnancy,
immunosupression,
antibiotic use,
diabetes

– Fluconazole 150
mg single dose

Not
usually
considere
d an STI.

BV

Vaginal
discharge or
malodorous in
childbearing
people. N

Mal-
odorous/
fishy odor,
thin gray-
white
discharge,
clue cells on

sexual activity,
particularly with
new or multiple
partners, the use of
douching, and not
using condoms

Metronidazole 500
mg BID x 7 days
OR 0.75% gel x 5
days

Not
sexually
transmittt
ed

Chlamydi
a

STI caused by
Chlamydia
trachomatis

Often
Asymptoma
tic;
cervicitis,
urethritis,
dysuria,
postcoital
bleeding

having multiple or
new sexual
partners, not using
condoms during
sex, and having a
history of other
STIs

Doxycycline 100
mg BID x 7 days
(preferred); or
Azithromycin 1 g
PO x1

Sexually
transmitt
ed;
screen
annually

Gonorrhe
a

STI caused by
Nisseria
gonorrheae

Purulent
discharge,
pelvic pain,
dysuria,
urethritis,
often
asymptomat
ic in women

unprotected sex,
having multiple
sexual partners, a
history of other
sexually
transmitted
infections (STIs),
and being a young
adult (under 25)

Ceftriaxone 500
mg IM x1 (if <150
kg); treat
Chlamydia
empirically unless
ruled out

Sexually
transmitt
ed,
screen
annually

Trichomo
nas

STI caused by
Trichomonas
vaginalis

Frothy
yellow-
green
discharge,
strawberry
cervix, foul
odor,

Multiple partners,
unprotected sex

Metronidazole 500
mg BID x 7 days
or 2g PO x1

Sexually
transmitt
ed,
partner
needs to
be
treated

Cervicitis
Inflammation
of cervix due
to STI

Mucopurule
nt
discharge,
cervical
bleeding
with contact

Chlamydia,
Gonorrhea, HSV

Treat based on
organism;
empirically cover
Chlamydia &
Gonorrhea

Can
cause
PID if
not
treater

PID

Ascending
polymicrobial
infection of
upper genital
tract

Pelvic pain,
cervical
motion
tenderness,
fever,
discharge

Untreated
Chlamydia/
Gonorrhea,
multiple partners

Ceftriaxone 500
mg IM x1 +
Doxycycline 100
mg BID x 14d

Metronidazole

Risk for
infertility

HIV

Human
immunodeficie
ncy virus , a
virus that
attacks cells
that help the
body fight
infection.
Affects the

Acute: flu-
like
symptoms

Chronic:
becomes
opportunisti
c infection

Unprotected sex,
IV drug use, MSM,
mother-to-child

ART
(Antiretroviral
therapy) – lifelong

Screenin
g should
be
offered
annually

Syphilis
STI caused by
treponema
pallidum

Primary:
Painless
chancre

Secondary:
rash on
palms, soles

Tertiary:
neurological
and cardiac
involvement

MSM, HIV+,
multiple partners,
unprotected sex

Benzathine
penicillin G 2.4M
units IM x1
(early); weekly x3
(late/unknown
duration)

Screen
all
pregnant
patients,
treat
partners.

Table 2

Hep B

hepatitis B
virus is a small
DNA virus that
belongs to the
“Hepadnavirid
ae” family.

Fatigue,
jaundice,
RUQ pain

Sexual contact, IV
drug use, perinatal
transmission,
healthcare
exposure

Supportive care
(acute); Antivirals
for chronic (e.g.,
tenofovir,
entecavir)

Screenin
g done to
all
pregnant
patients,
vaccine
available

Hep C

Hepatitis C is a
viral infection
that causes
liver swelling,
called
inflammation.
Hepatitis C can
lead to serious
liver damage.

Faituge,
jaundice

IV drug use, blood
transfusions
(pre-1992), sexual
exposure

Direct-acting
antivirals (e.g.,
sofosbuvir/
velpatasvir) for 8–
12 weeks

Screen
adults, no
vaccine
available

HSV

Herpes
Simplex Virus.
Herpes is a
common virus
that can cause
cold sores or
genital sores. It
spreads
through skin-
to-skin contact

Painless
vesciles or
ulcers,
dysuria,
systemic
symptoms
during
primary
infection

Oral/genital
contact,
unprotected sex,
vertical
transmission

Acyclovir 400 mg
TID x 7–10 days
or Valacyclovir 1g
BID x 7–10 days

Lifelong
therapy

Question Answer

Name 10 Risk Factors for contracting STI’s
and HIV

1. Having unprotected sex

2. Having multiple partners

3. Injection of drugs with dirty needle
sharing.

4. History of previous STI

5. Substance use

6. Sex work or transactional sex

7. Lac of access to healthcare or education

8. Not being vaccinated against preventable
STIs

9. Being incarcerated or having a partner
who is

10.Sexual coercion or violence

Name 5 safer sex practices

1. Limiting sexual partners

2. Regular STI testing, especially with new
partners

3. Use condoms every tine you have sex

4. Avoid sex under the influence of drugs or
alcohol

5. Inspect partners for visible sore or
symptoms

Can HIV be transmitted through sweat, saliva,
and tears? (Include rationale)

No, HIV can be transmitted from one infected
person to another through blood, semen,
vaginal secretions, rectal fluids and breast
milk. For HIV to occur, the HIV in these fluids
must get into the bloodstream of an HIV-
negative person through a mucous membrane
through open cuts or sores, or by direct
injection.

Lisa is a 19-year-old female who presents to the clinic c/o abnormal vaginal discharge for one
week after having unprotected vaginal intercourse with a new male partner she has been dating
for a couple of weeks. Lisa’s pregnancy test is negative and her LMP was 2 weeks ago. As her
health care provider, you will need to perform testing to determine if Lisa has contracted a
sexually transmitted infection or other vaginal infection.

SOAP NOTE

Demographic: 19/ Female G0P0

Subjective

Chief complain: “abnormal vaginal discharge for one week after having unprotected vaginal
intercourse with a new male partner that I have been dating for a couple of weeks.”

Name 2 types of intercourse are at the highest
risk for contracting HIV

1. Unprotected vaginal sex

2. Unprotected anal sex

Why are women more susceptible to HIV in a
male to female relationship (versus a male
contracting it from a female)?

In women, several factors can increase the risk
of HIV transmission. For example, during
vaginal or anal intercourse, women are at
greater risk of acquiring HIV because
receptive sex is generally riskier than insertive
sex. Age-related thinning and dryness of the
vaginal tissue—common in older women—
can lead to microtears during intercourse,
providing a pathway for HIV transmission.
Biologically, women are more vulnerable to
infection due to the larger mucosal surface
area exposed during penile penetration.
Additionally, young women under the age of
17 are at even higher risk because they have
an underdeveloped cervix and produce less
protective vaginal mucus.

HPI:

Lisa is a 19 year ld female G0P0 who presents with a one week history of abnormal discharge
after having unprotected vaginal intercourse with a new male partner.

• Onset: one week
• Locating: vaginal
• Duration: ongoing
• Characteristic: abnormal
• Aggrevating/relieving factors: none stated
• Treatment: none tried

HPI questions:

• Is there any vaginal itching, burning or odor?
• Are you having any symptoms such as cramping, pelvic pain, fever, burning when you pee?
• Have you had this type of discharge in the past?
• When was the last time you were tested for STIs?

Gyn history:

• LMP: 2 weeks ago, stated, regular
• Unknown if on birth control at this time
• Sexually active, new male partner, no protection
• No known gynocological issues at this time.

Medical history

• No known medical conditions
• No known surgical conditions
• No known drug allergies
• Immunizations: up to date

Family history:

• Mother: no known medical history
• Father: no known medical history
• Maternal grandmother: no known medical history
• Paternal grandmother: no known medical history,

Social history

• Goes to school

• Balanced diet
• Regular exercise
• No drug or alcohol use
• Sexual history: one new male partner, no protection
• Relationship: new

Other questions

• Are you in a monogamous relationship?
• Do you practice safe sex?

Review of systems:

• General: healthy, denies fever denies chills
• Neuro: denies headacces or dizziness
• Cardiovascular: denies chest pain or palpitations
• Resp: denies shortness of breaeth or cough
• GI: denies nausea, vomiting or diarrhea or abdominal pain
• GU: positive abnormal discharge
• Skin: denies rash, denies new lesions
• Health maintenance: No Pap in the last 12 months due to age

Objective

Vitals: WNL

• Temp: 98.6
• BP: 120/80
• HR:78
• RR: 17
• Heihgt: 5’4”
• Weight: 135
• BMI: 23.2

Physical exam:

• General: AAOx4, no acute distress
• abdomen soft, non tender
• Pelvic:

o Vulva: normal appearance
o Vagina: abnormal discharge
o Cervix: normal
o Uterus: non tender
o Adnexa: no masses or tenderness

POCT

• Urine pregnancy : negative
o Rule out pregnancy due to age and no condom use
• Wet mount with KOH and send out check for chlamydia, gonorrhea, BV, trichomonas
o KOH to help identify yeast, or bv or trichomonas cells
• NAAT
o For STI screening

Assessment

Final diagnosis:

• Vaginal candidiasis B37.3 – clinical presentation of abnormal discharge

Differential:

• Bacterial vaginosis N76.0 – due to new sexual partner after unprotected sex
• Trichomoniasis A59.9 – due to new sexual partner after unprotected sex
• Chlamydia A56.0 – due to new sexual partner after unprotected sex

Plan

Diagnostics:

• NAAT: Chlamydia, Gonorrhea and trichomonas
• KOH for BV
• Serology for HIV, syphilis, Hep B and C
• Pap smear

Treatments:

• Fluconazole 150 mg Po x 1 dose orally

o This medication is being prescribed at tis time as it is the first line therapy for uncomplicated
candidiasis, some of the side effects are GI upset, and elevated liver enzymes. This
medication should not be prescribed if patient has a history of liver disease.

If STI positive: depending on what STI patient comes back positive for, prescriptions will
change. Both patient and partner will need to be treated and abstain from sex for a week.

Patient education:

• Risk factors for STIs
• Abstain from sex for 7 days until symptoms have resolved, and medication taken
• Practice safe sex
• Refrain from having multiple partners as it can place you at higher risks for HIV andSTIs
• Routine STI screening

Complications: if untrearted can causes recurect yeast infectons, risk of spreading infection to
partner and increased risk for HIV and other STIs.

Referals: refer to GYN follow up

Follow up;

• Office will call when lab results return
• Follow up in one week if symptoms do not improve
• Pap smear

Health maintenance:

• Pap smear starting at age 21
• Hpv vaccine
• STI screening annualy or whena new partner
• Up to date on vaccines

November 5, 2026
[Solved] week 2 DB response

✓ Verified Academic Solution Available

Executive Solution Overview

see attachment – a year ago **files (1)** – ## Week2DBresponse–.pdf **## Week2DBresponse–.pdf** Infe ctio n Description Presentation Causes/Risk Factors Treatment per CDC Additional Info Can dida Fungal infection (yeast) Vulvar itching, thick white discharge Antibiotics use, diabetes, pregnancy, t…

Instant Solution Download
$6.99

Immediate access to the full model answer, formatted citations, and rubric breakdown.

Need a Fresh Custom Paper?

Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →

Assignment Prompt & Instructions

see attachment

– a year ago

**files (1)**

– ## Week2DBresponse–.pdf

**## Week2DBresponse–.pdf**

Infe
ctio
n

Description Presentation
Causes/Risk

Factors
Treatment per

CDC Additional Info

Can
dida

Fungal
infection
(yeast)

Vulvar
itching, thick
white
discharge

Antibiotics use,
diabetes,
pregnancy, tight
clothes

Fluconazole
150 mg PO
single dose

Not sexually
transmitted

BV
Bacterial
vaginosis

Thin gray
discharge,
fishy odor

Douching,
multiple partners,
new sex partner

Metronidazole
500 mg PO
BID x 7 days

Not an STI, but
related to sexual
activity

Chl
amy
dia

Bacterial STI

Often
asymptomatic,
discharge,
dysuria

Unprotected sex,
<25 yrs, multiple
partners

Doxycycline
100 mg BID x
7 days

Screen all
sexually active
females <25

Gon
orrh
ea

Bacterial STI
Purulent
discharge,
pelvic pain

Same as
chlamydia

Ceftriaxone
500 mg IM +
doxycycline

Often co-infected
with chlamydia

Tric
hom
onas

Protozoan
STI

Frothy
yellow-green
discharge,
odor

Unprotected sex,
multiple partners

Metronidazole
2g PO single
dose

Treat both
partners

Cer
vicit
is

Inflammation
of cervix
often due to
STI

Bleeding,
discharge,
pelvic pain

Chlamydia,
gonorrhea

Treat based on
causative
organism

Can lead to PID

PID

Infection of
upper
reproductive
tract

Pelvic pain,
fever, cervical
motion pain

Untreated STIs
Ceftriaxone +
doxycycline +
metronidazole

Risk for
infertility

HIV

Virus
affecting
immune
system

Fever, fatigue,
weight loss

Needle sharing,
sex, mother-to-
child

Antiretroviral
therapy (ART)

Lifelong
management

Syp
hilis

Bacterial STI
(Treponema
pallidum)

Chancre, rash,
systemic
symptoms

Sexual contact
with infected
person

Penicillin G
benzathine IM

Multiple stages;
test with RPR/
VDRL

Table 2: STI Knowledge Questions

SOAP Note – Tina, 27-year-old Female

Subjective:

Chief Complaint (CC):
“My vagina is burning, and I have painful blisters.”

HPI (OLDCARTS):

Hep
B

Liver
infection due
to HBV

Fatigue,
jaundice,
nausea

Sexual contact,
needle use

Supportive,
antivirals for
chronic cases

Vaccine available

Hep
C

Liver
infection due
to HCV

Often
asymptomatic,
may cause
fatigue

Blood-to-blood
contact, needle
sharing

Direct-acting
antivirals
(DAAs)

No vaccine;
chronic if
untreated

HS
V

Herpes
simplex virus
(type 1 or 2)

Painful
vesicles/
ulcers, fever

Sexual contact
Acyclovir,
Valacyclovir

Recurrent; no
cure, only
symptom
management

Question Answer

Name 10 Risk Factors for
contracting STIs and HIV

Unprotected sex, multiple partners, new partner, age <25,
MSM, history of STIs, drug use, sex work, inconsistent
condom use, partner with STI

Name 5 safer sex practices
Use condoms, limit partners, regular testing, mutual
monogamy, avoid sex under influence

Can HIV be transmitted
through sweat, saliva, and
tears?

No. HIV is not transmitted through sweat, saliva, or tears due
to insufficient viral load

Name 2 types of intercourse at
highest risk for contracting
HIV

Anal sex (receptive), vaginal sex (receptive)

Why are women more
susceptible to HIV in male-to-
female transmission?

Larger mucosal surface area exposed, higher viral load in
semen, potential microtears during sex

• The patient presented with a C/C of vaginal burning and painful blisters that began 3 days
ago. The area of concern is in her left labia minora. The patient describes that blisters as
painful and having a burning sensation with visible fluid-filled vesicles. Friction, urination,
and tight clothing worsen the pain. The patient describes relief with cool compresses, and
loose clothing. The discomfort is constant with intermittent sharp pain. She rates the pain a
6/10.

Medical History:

• no previous medical history

• no known allergies to drugs, food, or environmental factors

• no recent illnesses or hospitalizations

• vaccinations are up to date

Surgical History:

• No prior surgical history

Social History:

• #2 sexual partners in the last 6–12 months

• Use of protection (condoms)

• Tobacco, alcohol, recreational drug use, x2 a month socially

• sexual practices (oral, vaginal, anal)

Medications:

• Currently not on any medication

Allergies:

• NKDA (No Known Drug Allergies)

Objective:

Vital Signs:

• Temp: 98.6°F

• HR: 76 bpm

• BP: 112/70

• RR: 16/min

• SpO₂: 98% RA

Physical Exam:

• Genital Exam: Multiple small grouped vesicles on an erythematous base noted on the left
labia minora, tender to palpation. No foul-smelling discharge. No cervical motion tenderness.
No inguinal lymphadenopathy.

• Other Systems: Normal

Point of Care Testing (POCT):

• HSV PCR swab from lesion: High sensitivity and specificity for HSV-1 and HSV-2 (CDC,
2021)

• HIV rapid test: Recommended for new STI evaluation

• Urine NAAT for gonorrhea and chlamydia: Evaluate for co-infections

• Syphilis RPR and Hepatitis B/C screening: Per CDC recommendations for STI screening

Assessment/Diagnosis:

Presumptive Diagnosis:

• Genital Herpes Simplex Virus (HSV) Infection – ICD-10: A60.9

Rationale:

• Classic presentation of painful, fluid-filled vesicles on erythematous base, localized on labia
minora, recent unprotected sex, no previous known episodes.

Differential Diagnoses:

1. Contact Dermatitis: Less likely—symptoms typically bilateral and not vesicular.

2. Chancroid: Rare in the U.S.; painful ulcers with ragged borders, not grouped vesicles.

3. Syphilis (Primary): Typically a painless chancre; not vesicular.

Plan:

Pharmacologic Treatment (Assuming HSV PCR Positive):

• Acyclovir 400 mg tablet PO TID for 10 days

Patient Education:

• Medication Use: Take all medication as prescribed, even if symptoms improve early.

• Side Effects: May include nausea, headache, dizziness.

• Transmission: Avoid sexual activity until lesions are fully healed. HSV can be transmitted
even when asymptomatic.

• Safe Sex: Use condoms consistently to reduce recurrence transmission risk.

• Partner Notification: Partners should be informed and may need testing.

• Chronic Management: Discuss suppressive therapy if recurrences occur frequently (>6/
year).

Non-Pharmacologic Management:

• Keep area clean and dry.

• Use sitz baths and loose clothing.

• Apply cool compresses to soothe discomfort.

Follow-Up:

• Return to clinic in 1–2 weeks or sooner if symptoms worsen.

• Retesting or management for other STI test results as they return.

Complications of Non-Treatment:

• Increased risk of HIV transmission

• Severe and prolonged outbreaks, especially in immunocompromised patients

• Psychological distress

• Neonatal HSV transmission risk in future pregnancies

– Table 2: STI Knowledge Questions
– SOAP Note – Tina, 27-year-old Female
– Subjective:
– Objective:
– Assessment/Diagnosis:
– Plan:
– Pharmacologic Treatment (Assuming HSV PCR Positive):
– Patient Education:
– Non-Pharmacologic Management:
– Follow-Up:
– Complications of Non-Treatment:

**## Week2DBresponse–.pdf**

Infe
ctio
n

Description Presentation
Causes/Risk

Factors
Treatment per

CDC Additional Info

Can
dida

Fungal
infection
(yeast)

Vulvar
itching, thick
white
discharge

Antibiotics use,
diabetes,
pregnancy, tight
clothes

Fluconazole
150 mg PO
single dose

Not sexually
transmitted

BV
Bacterial
vaginosis

Thin gray
discharge,
fishy odor

Douching,
multiple partners,
new sex partner

Metronidazole
500 mg PO
BID x 7 days

Not an STI, but
related to sexual
activity

Chl
amy
dia

Bacterial STI

Often
asymptomatic,
discharge,
dysuria

Unprotected sex,
<25 yrs, multiple
partners

Doxycycline
100 mg BID x
7 days

Screen all
sexually active
females <25

Gon
orrh
ea

Bacterial STI
Purulent
discharge,
pelvic pain

Same as
chlamydia

Ceftriaxone
500 mg IM +
doxycycline

Often co-infected
with chlamydia

Tric
hom
onas

Protozoan
STI

Frothy
yellow-green
discharge,
odor

Unprotected sex,
multiple partners

Metronidazole
2g PO single
dose

Treat both
partners

Cer
vicit
is

Inflammation
of cervix
often due to
STI

Bleeding,
discharge,
pelvic pain

Chlamydia,
gonorrhea

Treat based on
causative
organism

Can lead to PID

PID

Infection of
upper
reproductive
tract

Pelvic pain,
fever, cervical
motion pain

Untreated STIs
Ceftriaxone +
doxycycline +
metronidazole

Risk for
infertility

HIV

Virus
affecting
immune
system

Fever, fatigue,
weight loss

Needle sharing,
sex, mother-to-
child

Antiretroviral
therapy (ART)

Lifelong
management

Syp
hilis

Bacterial STI
(Treponema
pallidum)

Chancre, rash,
systemic
symptoms

Sexual contact
with infected
person

Penicillin G
benzathine IM

Multiple stages;
test with RPR/
VDRL

Table 2: STI Knowledge Questions

SOAP Note – Tina, 27-year-old Female

Subjective:

Chief Complaint (CC):
“My vagina is burning, and I have painful blisters.”

HPI (OLDCARTS):

Hep
B

Liver
infection due
to HBV

Fatigue,
jaundice,
nausea

Sexual contact,
needle use

Supportive,
antivirals for
chronic cases

Vaccine available

Hep
C

Liver
infection due
to HCV

Often
asymptomatic,
may cause
fatigue

Blood-to-blood
contact, needle
sharing

Direct-acting
antivirals
(DAAs)

No vaccine;
chronic if
untreated

HS
V

Herpes
simplex virus
(type 1 or 2)

Painful
vesicles/
ulcers, fever

Sexual contact
Acyclovir,
Valacyclovir

Recurrent; no
cure, only
symptom
management

Question Answer

Name 10 Risk Factors for
contracting STIs and HIV

Unprotected sex, multiple partners, new partner, age <25,
MSM, history of STIs, drug use, sex work, inconsistent
condom use, partner with STI

Name 5 safer sex practices
Use condoms, limit partners, regular testing, mutual
monogamy, avoid sex under influence

Can HIV be transmitted
through sweat, saliva, and
tears?

No. HIV is not transmitted through sweat, saliva, or tears due
to insufficient viral load

Name 2 types of intercourse at
highest risk for contracting
HIV

Anal sex (receptive), vaginal sex (receptive)

Why are women more
susceptible to HIV in male-to-
female transmission?

Larger mucosal surface area exposed, higher viral load in
semen, potential microtears during sex

• The patient presented with a C/C of vaginal burning and painful blisters that began 3 days
ago. The area of concern is in her left labia minora. The patient describes that blisters as
painful and having a burning sensation with visible fluid-filled vesicles. Friction, urination,
and tight clothing worsen the pain. The patient describes relief with cool compresses, and
loose clothing. The discomfort is constant with intermittent sharp pain. She rates the pain a
6/10.

Medical History:

• no previous medical history

• no known allergies to drugs, food, or environmental factors

• no recent illnesses or hospitalizations

• vaccinations are up to date

Surgical History:

• No prior surgical history

Social History:

• #2 sexual partners in the last 6–12 months

• Use of protection (condoms)

• Tobacco, alcohol, recreational drug use, x2 a month socially

• sexual practices (oral, vaginal, anal)

Medications:

• Currently not on any medication

Allergies:

• NKDA (No Known Drug Allergies)

Objective:

Vital Signs:

• Temp: 98.6°F

• HR: 76 bpm

• BP: 112/70

• RR: 16/min

• SpO₂: 98% RA

Physical Exam:

• Genital Exam: Multiple small grouped vesicles on an erythematous base noted on the left
labia minora, tender to palpation. No foul-smelling discharge. No cervical motion tenderness.
No inguinal lymphadenopathy.

• Other Systems: Normal

Point of Care Testing (POCT):

• HSV PCR swab from lesion: High sensitivity and specificity for HSV-1 and HSV-2 (CDC,
2021)

• HIV rapid test: Recommended for new STI evaluation

• Urine NAAT for gonorrhea and chlamydia: Evaluate for co-infections

• Syphilis RPR and Hepatitis B/C screening: Per CDC recommendations for STI screening

Assessment/Diagnosis:

Presumptive Diagnosis:

• Genital Herpes Simplex Virus (HSV) Infection – ICD-10: A60.9

Rationale:

• Classic presentation of painful, fluid-filled vesicles on erythematous base, localized on labia
minora, recent unprotected sex, no previous known episodes.

Differential Diagnoses:

1. Contact Dermatitis: Less likely—symptoms typically bilateral and not vesicular.

2. Chancroid: Rare in the U.S.; painful ulcers with ragged borders, not grouped vesicles.

3. Syphilis (Primary): Typically a painless chancre; not vesicular.

Plan:

Pharmacologic Treatment (Assuming HSV PCR Positive):

• Acyclovir 400 mg tablet PO TID for 10 days

Patient Education:

• Medication Use: Take all medication as prescribed, even if symptoms improve early.

• Side Effects: May include nausea, headache, dizziness.

• Transmission: Avoid sexual activity until lesions are fully healed. HSV can be transmitted
even when asymptomatic.

• Safe Sex: Use condoms consistently to reduce recurrence transmission risk.

• Partner Notification: Partners should be informed and may need testing.

• Chronic Management: Discuss suppressive therapy if recurrences occur frequently (>6/
year).

Non-Pharmacologic Management:

• Keep area clean and dry.

• Use sitz baths and loose clothing.

• Apply cool compresses to soothe discomfort.

Follow-Up:

• Return to clinic in 1–2 weeks or sooner if symptoms worsen.

• Retesting or management for other STI test results as they return.

Complications of Non-Treatment:

• Increased risk of HIV transmission

• Severe and prolonged outbreaks, especially in immunocompromised patients

• Psychological distress

• Neonatal HSV transmission risk in future pregnancies

– Table 2: STI Knowledge Questions
– SOAP Note – Tina, 27-year-old Female
– Subjective:
– Objective:
– Assessment/Diagnosis:
– Plan:
– Pharmacologic Treatment (Assuming HSV PCR Positive):
– Patient Education:
– Non-Pharmacologic Management:
– Follow-Up:
– Complications of Non-Treatment:

November 5, 2026
[Solved] W-DISC 3

✓ Verified Academic Solution Available

Executive Solution Overview

PLEASE SEE ATTACHED DOCUMENT FOR INSTRUCTIONS AND REQUIREMENT DUE DATE MAY 18, 2025 NO PALGIO MORE THAN 10% 400 WORDS MINIMUM – [\ \ DISCUSSION.docx](https://www.sweetstudy.com/files/discussion-docx-10293873 "DISCUSSION.docx") – a year ago

Instant Solution Download
$6.99

Immediate access to the full model answer, formatted citations, and rubric breakdown.

Need a Fresh Custom Paper?

Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →

Assignment Prompt & Instructions

PLEASE SEE ATTACHED DOCUMENT FOR INSTRUCTIONS AND REQUIREMENT

DUE DATE MAY 18, 2025

NO PALGIO MORE THAN 10%

400 WORDS MINIMUM

– [\
\
DISCUSSION.docx](https://www.sweetstudy.com/files/discussion-docx-10293873 "DISCUSSION.docx")

– a year ago

November 5, 2026
[Solved] Summarize why you believe this nursing practice problem (pressure injury) is an issue in your current or past area of practice.

✓ Verified Academic Solution Available

Executive Solution Overview

In-depth study guidance and analytical solution covering Summarize why you believe this nursing practice problem (pressure injury) is an issue in your current or past area of practice..

Instant Solution Download
$6.99

Immediate access to the full model answer, formatted citations, and rubric breakdown.

Need a Fresh Custom Paper?

Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →

Assignment Prompt & Instructions

Full assignment prompt and step-by-step guidance are included in the downloadable solution file.

November 5, 2026